These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6653648)

  • 1. Diazoxide and labetalol in acute hypertension during haemodialysis.
    Keusch G; Schiffl H; Binswanger U
    Eur J Clin Pharmacol; 1983; 25(4):523-7. PubMed ID: 6653648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z; Bagatin J; Vidovic A
    Int J Clin Pharmacol Res; 1983; 3(1):47-54. PubMed ID: 6679507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK; Thomas GW; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Nov; 2(9):499-500. PubMed ID: 522807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
    Michael CA
    Aust N Z J Obstet Gynaecol; 1986 Feb; 26(1):26-9. PubMed ID: 3524548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z; Bagatin J; Vidović A
    Lijec Vjesn; 1980 Nov; 102(11):619-23. PubMed ID: 7024692
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of long-term treatment with labetalol.
    Waal-Manning HJ; Simpson FO
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):65S-73S. PubMed ID: 6980012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous labetalol in hypertensive patients given by fast and slow injection.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.